Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$403K Sell
3,138
-23
-0.7% -$2.69K 0.13% 138
2026
Q1
$380K Buy
3,161
+277
+10% +$32K 0.13% 137
2025
Q4
$304K Buy
2,884
+2,872
+23,933% +$270K 0.11% 153
2025
Q3
$999 Buy
+12
New +$988 ﹤0.01% 295

Other funds holding MRK

MMA Asset Management's MRK Position: Q2 2026 in Review

MMA Asset Management reduced its Merck (MRK) stake by 0.73% in Q2 2026, selling an estimated $2.69K and leaving 3,138 shares worth $403K. The position accounts for 0.13% of the portfolio, ranked #138.

MMA Asset Management first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 2,239 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • MMA Asset Management held 3,138 shares of Merck worth $403K as of Q2 2026.
  • MMA Asset Management sold 23 Merck shares in Q2 2026, an estimated $2.69K.
  • Merck made up 0.13% of MMA Asset Management's portfolio in Q2 2026, its #138 holding.
  • MMA Asset Management first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 2,239 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on MMA Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.